A phase II study of cabozantinib (cabo) alone or in combination with trastuzumab (T) in patients (pts) with breast cancer brain metastases (BCBM)

被引：0
|
作者：
Leone, Jose Pablo
Hu, Jiani
Barry, William Thomas
Duda, Dan G.
Gerstner, Elizabeth Robins
Jain, Rakesh K.
Tan, Sally
Lawler, Elizabeth S.
Winer, Eric P.
Lin, Nancy U.
Tolaney, Sara M.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1026
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases
    Leone, Jose Pablo
    Duda, Dan G.
    Hu, Jiani
    Barry, William T.
    Trippa, Lorenzo
    Gerstner, Elizabeth R.
    Jain, Rakesh K.
    Tan, Sally
    Lawler, Elizabeth
    Winer, Eric P.
    Lin, Nancy U.
    Tolaney, Sara M.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 179 (01) : 113 - 123
  • [2] A phase II study of cabozantinib alone or in combination with trastuzumab in breast cancer patients with brain metastases
    José Pablo Leone
    Dan G. Duda
    Jiani Hu
    William T. Barry
    Lorenzo Trippa
    Elizabeth R. Gerstner
    Rakesh K. Jain
    Sally Tan
    Elizabeth Lawler
    Eric P. Winer
    Nancy U. Lin
    Sara M. Tolaney
    Breast Cancer Research and Treatment, 2020, 179 : 113 - 123
  • [3] Phase II trial of carboplatin (C) and bevacizumab (BEV) in patients (pts) with breast cancer brain metastases (BCBM).
    Lin, Nancy U.
    Gelman, Rebecca Sue
    Younger, W. Jerry
    Sohl, Jessica
    Freedman, Rachel A.
    Sorensen, A. Gregory
    Bullitt, Elizabeth
    Harris, Gordon J.
    Morganstern, Daniel
    Schneider, Bryan P.
    Krop, Ian E.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Phase II trial of GDC0084 in combination with trastuzumab for patients with HER2-positive breast cancer brain metastases (BCBM)
    Leone, Jose P.
    Trippa, Lorenzo
    Milisits, Lindsey
    Andrews, Chelsea
    Ligibel, Jennifer
    Parsons, Heather
    Bi, Wenya L.
    Zhao, Jean
    Winer, Eric P.
    Lin, Nancy U.
    CANCER RESEARCH, 2020, 80 (04)
  • [5] LCCC 1025: Phase II study of everolimus, trastuzumab, and vinorelbine for HER2+breast cancer brain metastases (BCBM).
    Anders, Carey K.
    Deal, Allison Mary
    Van Swearingen, Amanda Elyse Day
    Siegel, Marni
    Hayes, David N.
    Jo, Heejoon
    Little, Paul
    Dees, Elizabeth Claire
    Muss, Hyman B.
    Jolly, Trevor Augustus
    Zagar, Timothy
    Smith, J. Keith
    Fisher, Julie Gottlieb
    Shah, Nikita C.
    Nabell, Lisle
    Nanda, Rita
    Dillon, Patrick Michael
    Puhalla, Shannon
    Abramson, Vandana Gupta
    Carey, Lisa A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [6] New graded prognostic index for breast cancer patients (pts) with brain metastases (BCBM).
    Ahluwalia, Manmeet Singh
    Du, Lingling
    Venur, Vyshak Alva
    Angelov, Lilyana
    Chao, Samuel T.
    Elson, Paul
    Mohammadi, Alireza Mohammad
    Peereboom, David M.
    Budd, G. Thomas
    Barnett, Gene H.
    Suh, John H.
    Abraham, Jame
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Preclinical and clinical efficacy of trastuzumab deruxtecan in breast cancer brain metastases (BCBM)
    Kabraji, Sheheryar
    Ni, Jing
    Sammons, Sarah
    Van Swearingen, Amanda E. D.
    Wang, Yanzhi
    Pereslete, Alyssa M.
    Hsu, Liangge
    Lascola, Chris
    Moore, Heather
    Hughes, Melissa
    Raghavendra, Akshara S.
    Gule-Monroe, Maria
    Murthy, Rashmi K.
    Winer, Eric P.
    Anders, Carey K.
    Zhao, Jean J.
    Lin, Nancy U.
    CANCER RESEARCH, 2022, 82 (04)
  • [8] Phase II trial of patupilone in patients (pts) with breast cancer brain metastases (BCBM) progressing or recurring after whole brain radiation therapy (WBXRT)
    Conlin, A. K.
    D'Andrea, G.
    Hudis, C. A.
    Robson, M. E.
    Drullinsky, P.
    Theodoulou, M.
    Lis, E.
    Kang, T. Y.
    Peereboom, D. M.
    Seidman, A. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Phase II study of cabozantinib (cabo) in patients (pts) with recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago, and California phase II consortia.
    Dhani, Neesha C.
    Hirte, Hal W.
    Burnier, Julia V.
    Jain, Angela
    Butler, Marcus .
    Lheureux, Stephanie
    Hurteau, Jean
    Welch, Stephen
    Matsuo, Koji
    Method, Michael
    Jimenez, Waldo
    Johnston, Carolyn
    Stringer, Erica
    Cristea, Mihaela C.
    Mehta, Anjali
    Quintos, Judy
    Tan, Susie
    Wang, Lisa
    Wright, John Joseph
    Oza, Amit M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] High incidence of brain metastases in advanced breast cancer (AB) patients (PTS) treated with trastuzumab
    Malossi, A.
    Seles, E.
    Sozzi, P.
    Paris, M. K.
    Cantele, V
    Clerico, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI12 - XI12
12345